News
Marlborough, Massachusetts--(Newsfile Corp. - April 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biotechnology company developing therapeutics using its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback